期刊:Science [American Association for the Advancement of Science] 日期:2020-04-02卷期号:368 (6486): 42.10-44
标识
DOI:10.1126/science.368.6486.42-j
摘要
Molecular Biology
Poly(ADP-ribose) polymerase–1 (PARP-1) binds to DNA breaks and recruits DNA repair components. Cancer-killing PARP-1 inhibitor (PARPi) compounds all block the same catalytic site but exhibit vastly different efficacy. Zandarashvili et al. investigated the molecular impact of PARPi binding to PARP-1 (see the Perspective by Slade and Eustermann). Different PARPi molecules perturb PARP-1 allostery in diverse manners: Some drive allostery to promote release of PARP-1 from DNA, and others drive allostery to promote retention. These insights help explain the different efficacies in the clinic and enable conversion of a pro-release, ineffective cancer-killing compound to a pro-retention, more effective PARPi.
Science , this issue p. [eaax6367][1]; see also p. [30][2]
[1]: /lookup/doi/10.1126/science.aax6367
[2]: /lookup/doi/10.1126/science.abb1462